Search
You're invited to try out the new version of Value Research Online. Click here to begin: https://beta.valueresearchonline.com

NGL Fine-Chem

Sector: Healthcare | Industry: Drugs & Pharma
R 514.50 -4.15  | -0.80% 3.51% 15.25 317.86
BSE Price: Oct 15, 2019 Change R    |  % 1-Year Change P/E Market Cap (R Cr)
BSE Oct 15, 2019 514.50 -4.15 -0.80% 525.95 518.65 873 511.00 - 539.90
Exchange & Time Last Price      Day Change Open Prev Close Volume    1-Day Range
SUBSCRIBE TO THE VALUE RESEARCH STOCK INSIGHT NEWSLETTER
6M Average Volume: 1,887 P/B: 3.25 NSE Code:
52-Week Range: R 390.05 - 620.00 Dividend Yield: 0.34% BSE Code: 524774
TTM EPS: R 33.74 Book Value: R 158.09 Face Value: R 5
Number of stocks currently recommended as 'Buy' by Value Research Stock Advisor: 38
Price Graph
  • Eris Lifesciences (BSE)
  • S&P BSE Sensex


Please wait while we are fetching data...
Are you missing an opportunity to invest in great stocks at low valuations?
There are thousands of listed companies in India and yet only a handful that are worth investing at a particular time and at a particular price.

Our equity team has sifted through hundreds of companies and selected stocks that you should invest in. This list now has 38 stocks on it, and new ones are being added every month. Thousands of our members are using stagnant equity markets to buy great stocks at low prices. Membership of Value Research Stock Advisor is available at a 40% to 60% discount. Learn more and become a member
Performance
  YTD 1-Month 3-Month 1-Year 3-Year 5-Year 10-Year
NGL Fine-Chem 18.26 4.44 1.91 3.51 16.58 58.75 43.36
S&P BSE Small Cap* -13.05 -1.73 -7.18 -9.64 -0.99 3.76 5.39
S&P BSE Healthcare* -11.96 -5.87 -5.15 -15.12 -8.79 -2.02 10.48
Company's return has been calculated on basis of BSE's price.
As on Oct 15, 2019
*As on Oct 14, 2019
Key Ratios
Revenue Per Share (R) Earnings Per Share (R) Return on Networth (%)


Please wait
while we are fetching data...


Please wait
while we are fetching data...


Please wait
while we are fetching data...
Annual Ratios (%)
  1-Year 3-Years 5-Years
Growth
Revenue 34.77 16.73 14.20
Net Profit 58.97 20.78 34.70
EPS 58.97 20.78 34.70
Book Value 27.87 27.72 30.28
Average
Operating Margin 23.73 23.99 22.42
Net Margin 12.77 12.78 11.92
Return on Networth 24.46 24.14 26.21
Return on Investment 27.57 27.69 30.65
Interim Growth Ratios (%)
  QoQ YoY YTD
Quarterly
Revenue -6.35 16.77 -6.35
Operating Profit -16.30 35.44 -16.30
Net Profit -18.55 15.02 -18.55
EPS -18.55 15.02 -18.55
TTM
Revenue 3.85 25.98 3.85
Operating Profit 7.23 38.78 7.23
Net Profit 3.60 34.17 3.60
EPS 3.60 34.17 3.60
Peer Comparison
  Market Cap
(R Cr)
Revenue
(R Cr)
Net Profit
(R Cr)
Net Margin (%) RoE (%) Price to Book Price to Earnings
NGL Fine-Chem 317.86 157.55 20.84 12.81 24.46 3.25 15.25
Astrazeneca Pharma India 5,337.38 771.42 69.56 8.84 20.03 16.67 76.73
Eris Lifesciences 5,801.96 1,005.70 303.64 29.29 28.96 4.70 19.11
Insider Trades
Date Person  Buy / Sell Transaction
Type
No of Shares Price
(R)   
Value
(R Lakhs)
May 09, 2013 Jyoti Arun Lawande  Sell Market 600 17.70 0.11
News & Announcements
Contact Information

Company: NGL Fine-Chem Ltd.

Address: 301 E Square, Subhash Road, Vile Parle (East), Mumbai, Maharashtra - 400057 | Phone: 022 2663 6450

Email: [email protected]

Website: www.nglfinechem.com

Registrar & Transfer Agent: Purva Shareregistry (India) Pvt Ltd

Address: Gala No 9, Shiv Shakti, Industrial EstateSitaram Mill Compound, J R Boricha Marg, Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E]

Essential checks
Altman Z-Score
6.21
Piotroski F-Score
8
Modified C-Score
2
5-Years Price to Earnings
15.25
5-Years Price to Book
3.25
Earnings Yield
EBIT / Enterprise value
9.69%
PEG
Price / Earnings to growth ratio
0.45
Related Stocks
  Current Price   Chng %
Astrazeneca Pharma India R2,134.25 -1.66%
Caplin Point Laboratories R398.40 -0.91%
Eris Lifesciences R424.80 -1.72%
FDC R159.35 -0.50%
JB Chemicals & Pharma R356.05 -0.96%
Laurus Labs R319.55 -0.11%
Strides Pharma Science R355.60 +5.05%
Sun Pharma Adv. Research R119.90 +0.88%
Suven Life Sciences R265.70 +2.90%
Wockhardt R253.55 -0.06%
As on Oct 15, 15:59